ENHANCED SERUM RESPONSE ELEMENT-BINDING ACTIVITY CORRELATES WITH DOWN-REGULATION OF C-FOS MESSENGER-RNA EXPRESSION IN THE RAT-BRAIN FOLLOWING REPEATED CORTICAL-LESIONS
S. Ivkovic et al., ENHANCED SERUM RESPONSE ELEMENT-BINDING ACTIVITY CORRELATES WITH DOWN-REGULATION OF C-FOS MESSENGER-RNA EXPRESSION IN THE RAT-BRAIN FOLLOWING REPEATED CORTICAL-LESIONS, Molecular brain research, 52(1), 1997, pp. 62-70
Repeated lesions of rat cerebral cortex result in transient peaks in t
he level of the c-fos transcript, but after the second lesion, this pe
ak is substantially diminished. Using this lesion paradigm, we have an
alyzed the participation of the c-fos promoter elements SRE and DSE in
the regulation of c-fos transcription. Following a single lesion, SRE
/DSE binding activity peaked at 2 h, subsequent to the maximal levels
of c-fos mRNA and parallel to the peak of c-Fos protein. After a secon
d lesion (reinduction), 4 h following the initial lesion, SRE/DSE bind
ing activity peaked after only 30 min and was significantly higher tha
n following the first lesion. Once again, this peak occurred after the
peak of c-fos mRNA expression and parallel with the second peak of c-
Fos protein expression. These results suggested that the SRE and DSE p
romoter elements participated in the induction and down-regulation of
c-fos transcription in vivo and suggested the possible involvement of
Fos protein in its own regulation. The ability of Fos/Fra proteins to
participate in a transcriptional complex was confirmed in gel-shift ex
periments with an AP-1 element, and the biphasic trend of binding acti
vity was observed. Supershift experiments were performed to directly d
etermine whether Fos protein was participating in SRE and/or DSE trans
criptional complexes. No alterations in the position or intensity of t
he shifted band were observed using Fos/Fra antiserum suggesting that
Fos/Fra proteins could be involved in c-fos down-regulation through me
chanisms other than direct participation in the SRE/DSE transcription
complex. (C) 1997 Elsevier Science B.V.